Navigation Links
Myeloma in Medical News

Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma

... in relapsed or relapsed / refractory multiple myeloma patients previously treated with bortezomib ... of Bortezomib and Dexamethasone in Multiple myeloma Patients Previously Treated with Bortezomib" will ... "Perifosine holds great promise for multiple myeloma patients worldwide. We at Dana-Farber, along ...

Multiple Myeloma Genome Unlocked

... -- The sequencing of the first three multiple myeloma whole genomes has been completed by U.S. ... samples was conducted as part of the Multiple myeloma Genomics Initiative. Overall, more than 250 ... have been collected and additional multiple myeloma genomes are being sequenced, according to a news ...

CancerCare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs

... grants of up to $600 annually to multiple myeloma patients for covering transportation costs such ... to people affected by cancer. Multiple myeloma is a cancer of the bone marrow that is diagnosed ... therapies and the disease itself, many multiple myeloma patients may be required to visit their doctors ...

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

... report to its catalogue. World Multiple myeloma Therapeutics Market ... This report analyzes the US market for Multiple myeloma Therapeutics in Millions of US$. The market for multiple myeloma therapeutics is analyzed by the following Drugs: ...

Individuals Who Apply Pesticides Are Found to Have Double the Risk of Blood Disorder

... linked agricultural work to an increased multiple myeloma risk. Our study is the first to show an ... screening study that virtually all multiple myeloma patients experienced a MGUS state prior to ... malignancies (such as multiple myeloma or lymphoma) were excluded. Cancer incidence and ...

Cancer research partnership between UCSF, MMRF to drive drug development

... California, San Francisco (UCSF) and the Multiple myeloma Research Foundation (MMRF) have established the Stephen and Nancy Grand Multiple myeloma Translational Initiative, a research ... San Francisco. Mr. Grand, age 65, is a multiple myeloma patient at the UCSF Helen Diller Family ...

More>>

Myeloma in Medical Technology

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... breast and prostate cancer) or multiple myeloma and bone metastases. Secondary endpoints were to ... to the spread of cancer to the bone in multiple myeloma and multiple solid tumors, and for its potential ... with incidence rates of nearly 100 percent in myeloma patients and as high as 75 percent in solid tumor ...

Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting

... Phase 2 Trial of Relapsed and Refractory Multiple myeloma Patients - Proteolix Expands Trial ORLANDO, ... trial of relapsed and refractory multiple myeloma patients were presented today in an oral session by Sundar Jagannath, M.D., Chief of the Multiple myeloma Program, Bone Marrow and Blood Stem Cell ...

Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting

... a Phase 3 clinical trial in relapsed multiple myeloma patients." About Carfilzomib Carfilzomib ... by Proteolix in collaboration with the Multiple myeloma Research Consortium (MMRC). A Phase Ib clinical ... dexamethasone in patients with relapsed multiple myeloma is also ongoing. In addition, Proteolix is ...

New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers

... reduce the number of cancerous cells in multiple myeloma patients and improve patient health and ... a Phase 1 trial in patients with multiple myeloma and to date six patients have been treated at The ... is seeking to enroll another nine multiple myeloma patients with the kappa form of the disease to be ...

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

... ("rHuEPO") for the prolongation of multiple myeloma ("MM") patients' survival and improvement of ... and cancer-related anemia. ABOUT MULTIPLE myeloma Currently incurable, MM is a severe plasma ... of therapeutics for the treatment of multiple myeloma and hepatitis C. XTL will be developing rHuEPO ...

Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting

... featured at the 12th International Multiple myeloma Workshop in Washington, DC, highlights a subset ... with Relapsed or Relapsed / Refractory Multiple myeloma Who Were Previously Treated with Bortezomib." ... multiple myeloma." One additional multiple myeloma clinical poster was presented as follows: ...

More>>

Myeloma in Medical Products

Multiple Myeloma Panel by FISH

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...
Company:ARUP Laboratories

Chromosome Analysis, Multiple Myeloma Panel by FISH

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...
Company:ARUP Laboratories
Myeloma in Medical Definition

Hematopathology

... ( ALL , CLL , HCL ) • Lymphoma ( Hodgkin's disease , NHL ) • LPD • myeloma ( Multiple myeloma , Extramedullary plasmacytoma ) Myeloid : Myeloid leukemia ( AML , ...

Pathology

... ( ALL , CLL , HCL ) • Lymphoma ( Hodgkin's disease , NHL ) • LPD • myeloma ( Multiple myeloma , Extramedullary plasmacytoma ) Myeloid : Myeloid leukemia ( AML , ...
Myeloma in Medical Dictionary

Amyloidosis

... from a cancer of the blood cells called myeloma . Hereditary amyloidosis is an inherited form ... ... Amyloidosis Web Resources International myeloma Foundation Multiple myeloma Research Foundation American Cancer Society ...

Multi

... Multi ple myeloma can result in several complications: Impaired immunity . myeloma cells inhibit the production of antibodies needed for normal immunity . Multi ple myeloma - Learn more about multi ...

Multiple myeloma

... Multiple myeloma can result in several complications: Impaired immunity . myeloma cells inhibit the production of antibodies needed for normal immunity . Multiple myeloma /Other Plasma Cell Neoplasm s Related Pages ...

Myeloma

... myeloma : A tumor of antibody -producing cells, called ... For: search help Printer-Friendly Format ... myeloma SPOREs Leukemia / Lymphoma / myeloma PRG Report Strategic Plan for Leukemia , ...

Neoplasm

... type and location of the tumor . Multiple myeloma /Other Plasma Cell Neoplasm s Related Pages What You Need To Know About™ Multiple myeloma Information about detection, symptoms, diagnosis , and treatment of multiple myeloma . NIH Publication No. 05-1575 ... Neoplasm a; ...

Plasma

... complex or plasma disease s. Multiple myeloma /Other Plasma Cell Neoplasm s Related Pages What You Need To Know About™ Multiple myeloma Information about detection, symptoms, diagnosis , and treatment of multiple myeloma . NIH Publication No. 05-1575 ... Plasma ...

More>>

Myeloma in Biological News

TGen helps promote cancer awareness for vast Navajo Nation

... and Advocacy Conference, sponsored by the Arizona myeloma Network, is planned 8:30 a.m.-5 p.m. July 18 at ... and chief executive officer of the Arizona myeloma Network, which provides outreach and education ... who is investigating breast cancer and multiple myeloma in TGen's Integrated Cancer Genomics Division. ....

U of MN study shows link between gene variations and cancer survival

... used genetic information that the International myeloma Foundation has gathered from myeloma patients worldwide through its program, Bank On A ... of the major treatment and research centers for myeloma worldwide and thousands ...

The IMF says journal editorial documents dramatic increase in survival since the 1980s

... CA September 11, 2008 - The International myeloma Foundation (IMF)supporting research and providing education, advocacy and support for myeloma patients, families, researchers and ... 25 years ago only 48 percent to 66 percent of myeloma patients survived two years, depending on which ...

Looking through the eyes of a mouse, scientists monitor circulating cells in its bloodstream

... cells is important in diseases like multiple myeloma because the number of cancer cells in the ... cells nevertheless can be relentless. Multiple myeloma starts when cancerous immune system cells ... out other cells in the bloodstream. Multiple myeloma cells can invade bones throughout the body, ...

Getting down to cancer basics

... gene on the X chromosome called UTX - is found in 10% of cases of multiple myeloma and 8% of esophageal cancers. UTX plays a role in overall regulation of ... they found mutations in many cancer types - including one in ten multiple myeloma and one in twelve esophageal cancer cases. "This work shows that ...

Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma

... the development of more effective therapies for individuals with multiple myeloma (MM), a common and incurable blood cell cancer. The research, published by ... targeted disruption of the classical NF-κB signaling blocked myeloma proliferation and induced cell death. These genetic and functional data ...

More>>

Myeloma in Biological Technology

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

... in relapsed or relapsed/refractory multiple myeloma patients previously treated with bortezomib ... of Bortezomib and Dexamethasone in Multiple myeloma Patients Previously Treated with Bortezomib", ... overall survival and safety. About Multiple myeloma Multiple myeloma, a cancer of the plasma ...

Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association

... of carfilzomib for the treatment of multiple myeloma at the 14th Congress of the European Hematology ... and solid tumors. Relapsed Multiple myeloma Patients Achieve Responses with Single-Agent ... of single-agent carfilzomib in relapsed multiple myeloma patients. Patients in the study have relapsed ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... (B) versus B alone in previously treated multiple myeloma (MM) (Abstract 8591) General Poster Session, ... for the treatment of patients with multiple myeloma who have not previously received VELCADE and have ... injury In the randomized multiple myeloma study, 25 patients (8%) in the VELCADE for ...

Proteolix to Present Carfilzomib Clinical Data During the 2009 ASCO Annual Meeting

... of Carfilzomib in Relapsed/Refractory Multiple myeloma and Advanced Solid Tumors Featured in Oral ... from clinical trials of carfilzomib in multiple myeloma and advanced solid tumors will be presented at ... approval study in relapsed/refractory multiple myeloma and Phase 2 clinical studies in relapsed ...

Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results

... in mice for SNS-01, the Company's multiple myeloma drug candidate. Management delivered the ... application for SNS-01, the Company's multiple myeloma drug candidate, before the end of calendar year ... programs, specifically the Company's multiple myeloma research program, which was partially offset by a ...

Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results

... in mice for SNS-01, the Company's multiple myeloma drug candidate. Senesco's data was ... in Vivo". Senesco's preclinical multiple myeloma data was presented at the 20th EORTC-NCI-AACR ... programs, specifically the Company's multiple myeloma research program, which was partially offset by a ...

More>>

Myeloma in Biological Products

Mouse Anti-Mouse Natural Killer Cell Receptor-P1 Monoclonal Antibody, Unconjugated, Clone 1C10 from CHEMICON

Description:... produced by the fusion of splenocytes from BALB/c mice immunized (BALB/c X C57BL/6)F1 (CbyB6F1) lymphokine-activated killer (LAK) cells and mouse myeloma cellline. Available Date: ...
Company:CHEMICON

Mouse Anti-PRMT5 Monoclonal Antibody, Unconjugated, Clone PRMT5-21 from GeneTex

Description:... antibodies can be utilized to explore arginine methylation and its regulatory functions. Immunogen: Antibody was produced by the fusion of mouse myeloma cells and splenocytes from mice immunized with PRMT5 containing the C-terminal region of the Human PRMT5 (amino acids ....
Company:GeneTex

Hybridoma Development from QED Bioscience Inc.

Description:... 10-14 weeks ($1,845.00) PHASE II: FUSION 1. Spleen cells from selected animals are fused with two different myeloma cell lines. 2. Remaining fusion cocktail is frozen for future use, if necessary. Estimated completion time: 2-3 weeks ($3,690.00) ...
Company:QED Bioscience Inc.
Myeloma in Biological Definition

Monoclonal antibody

... the antigen. These B-cells are then fused with myeloma tumor cells that can grow indefinitely in ... called ascites fluid. In the above process, myeloma cell lines are used that have lost their ability ... the target antibody. Furthermore, one uses only myeloma cells that have lost a specific enzyme ( ...

Antibody

... (1 and 2), beta-globulins (1 and 2) and gamma-globulins according to weight. Immunoglobulins are all in the gamma region. In some disease states ( myeloma ) a very high concentration of one particular immunoglobulin will show up as a monoclonal band. Isotypes According to differences in their ...

Cancer

... , blood (and bone marrow ) - hematological malignancies , leukemia , lymphoma , Hodgkin's disease , non-Hodgkin's lymphoma , multiple myeloma , brain tumor , breast cancer , cervical cancer , colorectal cancer - in the colon , rectum , anus , or appendix , esophageal cancer , ...
Myeloma in Biological Dictionary

Plasma cells

... the bone marrow leads to ... In addition, the abnormal plasma cells almost always produce a large amount of a ... Clinical Trials for Multiple myeloma / Plasma Cell Neoplasms at UPMC ... The plasma cells make a different antibody to fight each type of bacteria or ... Information about ...

Hybridoma

... hybridoma mean? ... hybridoma /hy·brid·o·ma/ (hi′′brid-o'mah) a somatic cell hybrid formed by fusion ... fusion of B lymphocytes with myeloma cells to create hybridomas ... Through these initiatives, the Hybridoma Core will remain on the cutting edge of ... This tutorial ...

More>>

Other Contents
(Date:7/29/2014)... July 29, 2014 truBrain has created ... provided by energy drinks. Think Drinks , available ... that creates optimal conditions for memory, complex reasoning and ... hopes to raise $50,000 over the course of the ... mental boost and have compounding effects over time when ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Outsourced ... of tripling in the number of hospitals contracting ... 1, 2015 deadline, according to the recently published ... physician leaders, found in the reports “Top Ranked ... hospitals now outsource Clinical documentation audit, review and ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Biocides are ... and control bacteria or fungi growth and to prevent ... within the material and its surface. It is used ... wood preservation, food and beverage, paints and coatings. It ... and sanitizers, as well as in industrial applications to ...
(Date:7/29/2014)... increasing use of electronic medical records and health ... a computerized version of the preventive care guidelines ... new study, researchers from the Indiana University School ... substantial work lies ahead to convert the American ... prompts for physicians, but the payoff has the ...
(Date:7/29/2014)... 29, 2014 The Latin American poultry feed ... with analysis and forecast of revenue. The poultry feed and ... from $25,273.3 million and $647.2 million in 2013 to $34,024.0 ... 6.1% from 2013 to 2018, respectively. , To get an ... the TOC of the Latin American poultry feed and feed ...
Breaking Medicine News(10 mins):Health News:Focus- and Productivity-Enhancing Beverage Launches Crowdfunding Campaign on Indiegogo 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5
(Date:7/29/2014)... Achalasia is a rare disease it affects 1 in ... in the esophageal wall. While its cause remains unknown, a ... in Belgium, the University of Bonn in Germany and other ... autoimmune in origin. The study, published on 6 July in ... the mysterious disease. , When we swallow, a sphincter in ...
(Date:7/29/2014)... A new study from UC San Francisco is the ... stressors accumulate overtime and accelerate cellular aging, these negative ... exercising and sleeping well. , "The study participants ... telomere shortening than the ones who didn,t maintain healthy ... said lead author Eli Puterman, PhD, assistant professor in ...
(Date:7/28/2014)... communities showing signs of damage from the Deepwater Horizon oil ... the Gulf of Mexico. The discovery was made by a ... State University. A paper describing this work and additional impacts ... will be published during the last week of July 2014 ... of the National Academy of Sciences . , "The footprint ...
Breaking Biology News(10 mins):Mysterious esophagus disease is autoimmune after all 2Healthy lifestyle may buffer against stress-related cell aging, study says 2Impact of Deepwater Horizon oil spill on coral is deeper and broader than predicted 2
Other TagsOther Tags